BioNTech creates a multiple sclerosis vaccine

The experts behind the BioNTech coronavirus jab have developed another vaccine which they claim cures multiple sclerosis (MS) in mice.  The new MS vaccine works in a similar way to the coronavirus vaccine, manufactured in conjunction with US pharmaceutical giant Pfizer.  A piece of genetic material known as mRNA is inserted into a person’s arm … Read more

Inventor of Biontech jab adds $4bn to his fortune while his investors make EIGHT BILLION

The vaccine billionaires’ fortune grows: Inventor of Biontech jab adds $4bn to his fortune while his investors make EIGHT BILLION as countries scramble to inoculate populations Ugur Sahin has seen his wealth grow as share prices in German biotech firm soar Investors Thomas and Andreas Strungmann have profited even more as a result Share prices … Read more

Coronavirus vaccine from Pfizer and BioNTech approved by regulators in the UK for roll out in days

Pfizer’s coronavirus vaccine is APPROVED by regulators for use in UK and could be rolled out across the country NEXT WEEK Department of Health announced the news just after 7am this morning It came as England came out of its second national lockdown today  The Pfizer vaccine will reportedly be given staff first due to … Read more

Coronavirus vaccine from Pfizer and BioNTech has been approved by regulators for use in the UK an…

Coronavirus vaccine from Pfizer and BioNTech has been approved by regulators for use in the UK and will roll out NEXT WEEK By Dan Sales For Mailonline Published: 07:10 GMT, 2 December 2020 | Updated: 07:11 GMT, 2 December 2020 A Covid-19 vaccine from Pfizer/BioNTech has been approved by the Medicines and Healthcare products Regulatory … Read more

Britain signs deals with Pfizer, BioNTech, Valneva for Covid jabs

Britain has signed deals with two foreign pharmaceutical giants for 90million doses of different experimental vaccines amid fears one of the world’s leading candidates won’t be ready by September — despite academics saying it could be ready for the autumn.  Agreement has been reached for 30million doses from German firm BioNTech and Pfizer and 60million … Read more